As a substitute, the FDA recommended the development of a manufacturer-new regulatory pathway that could contain safeguards such as a minimum amount authorized buy age. But producing this kind of pathway would have to have an act of Congress — a thing unlikely to happen shortly.” However, she would discourage working with CBD to treat psycholog